Cargando…
CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia
The retinoid-responsive gene CXXC5 localizes to the 5q31.2 chromosomal region and encodes a retinoid-inducible nuclear factor (RINF) that seems important during normal myelopoiesis. We investigated CXXC5/RINF expression in primary human acute myeloid leukemia (AML) cells derived from 594 patients, a...
Autores principales: | Astori, Audrey, Fredly, Hanne, Aloysius, Thomas Aquinas, Bullinger, Lars, Mas, Véronique Mansat-De, de la Grange, Pierre, Delhommeau, François, Hagen, Karen Marie, Récher, Christian, Dusanter-Fourt, Isabelle, Knappskog, Stian, Lillehaug, Johan Richard, Pendino, Frédéric, Bruserudg, Øystein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824541/ https://www.ncbi.nlm.nih.gov/pubmed/23988457 |
Ejemplares similares
-
The epigenetic regulator RINF (CXXC5) maintains SMAD7 expression in human immature erythroid cells and sustains red blood cell expansion
por: Astori, Audrey, et al.
Publicado: (2020) -
Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation
por: Bruserud, Øystein, et al.
Publicado: (2014) -
Rinf Regulates Pluripotency Network Genes and Tet Enzymes in Embryonic Stem Cells
por: Ravichandran, Mirunalini, et al.
Publicado: (2019) -
FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells
por: Levavasseur, Francoise, et al.
Publicado: (2023) -
Adjuvant treatment: the contribution of expression microarrays
por: Lønning, Per Eystein, et al.
Publicado: (2007)